Pruzanski Mark

CIK 00015595692 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001559569

Recent Transactions

50 trades

Award
Equillium, Inc.$EQ
Director Stock Option (right to buy)
2025-05-21+20,000→ 20,000 total
Award
Equillium, Inc.$EQ
Director Stock Option (right to buy)
2025-02-14+20,770→ 20,770 total
Award
Equillium, Inc.$EQ
Director Stock Option (right to buy)
2025-02-14+12,000→ 12,000 total
Disposition to Issuer
Equillium, Inc.$EQ
Director Stock Option (right to buy)
2025-02-14−20,770→ 0 total
Award
Equillium, Inc.$EQ
Director Stock Option (right to buy)
2025-02-14+20,000→ 20,000 total
Disposition to Issuer
Equillium, Inc.$EQ
Director Stock Option (right to buy)
2025-02-14−24,000→ 0 total
Disposition to Issuer
Equillium, Inc.$EQ
Director Stock Option (right to buy)
2025-02-14−20,000→ 0 total
Disposition to Issuer
Equillium, Inc.$EQ
Director Stock Option (right to buy)
2025-02-14−12,000→ 0 total
Award
Equillium, Inc.$EQ
Director Stock Option (right to buy)
2025-02-14+24,000→ 24,000 total
Award
Equillium, Inc.$EQ
Stock Option (right to buy)
2024-05-22+20,000→ 20,000 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−332→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−17,700→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−889→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−5,401→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,811→ 0 total
Disposition from Tender
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−618,894→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−38,793→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−1,207→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−207→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−635→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−29,865→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−45,293→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−31,506→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−1,044→ 0 total
Award
Equillium, Inc.$EQ
Stock Option (right to buy)
2023-05-22+20,000→ 20,000 total
Award
Equillium, Inc.$EQ
Stock Option (right to buy)
2022-05-24+20,000→ 20,000 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-11-30$17.21/sh−3,817→ 618,894 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-11-30$17.21/sh+6,138→ 622,711 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-10-29$16.86/sh−3,817→ 616,573 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-10-29$16.86/sh+6,138→ 620,390 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-09-30$14.85/sh+6,136→ 618,068 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-09-30$14.85/sh−3,816→ 614,252 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-08-31$14.91/sh+6,138→ 615,749 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-08-31$14.91/sh−3,817→ 611,932 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-07-30$17.28/sh−3,817→ 609,611 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-07-30$17.28/sh+6,138→ 613,428 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-06-30$19.97/sh−3,816→ 607,290 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-06-30$19.97/sh+6,136→ 611,106 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-05-28$16.63/sh−3,817→ 604,970 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-05-28$16.63/sh+6,138→ 608,787 total
Award
Equillium, Inc.$EQ
Stock Option (right to buy)
2021-05-26+20,770→ 20,770 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-04-30$19.78/sh−3,817→ 502,649 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-04-30$19.78/sh+6,138→ 506,466 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-03-31$23.08/sh+6,136→ 503,986 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-03-31$23.08/sh−3,658→ 500,328 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-02-26$21.66/sh+6,138→ 500,591 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-02-26$21.66/sh−2,741→ 497,850 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-01-29$35.24/sh+6,138→ 497,194 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-01-29$35.24/sh−2,741→ 494,453 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-01-01$24.70/sh−632→ 491,056 total

Companies

Recent Filings

Address

C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES ST.

NEW YORK, NY, 10013

View on SEC.gov